Literature DB >> 26869315

Structure, expression and functions of MTA genes.

Rakesh Kumar1, Rui-An Wang2.   

Abstract

Metastatic associated proteins (MTA) are integrators of upstream regulatory signals with the ability to act as master coregulators for modifying gene transcriptional activity. The MTA family includes three genes and multiple alternatively spliced variants. The MTA proteins neither have their own enzymatic activity nor have been shown to directly interact with DNA. However, MTA proteins interact with a variety of chromatin remodeling factors and complexes with enzymatic activities for modulating the plasticity of nucleosomes, leading to the repression or derepression of target genes or other extra-nuclear and nucleosome remodeling and histone deacetylase (NuRD)-complex independent activities. The functions of MTA family members are driven by the steady state levels and subcellular localization of MTA proteins, the dynamic nature of modifying signals and enzymes, the structural features and post-translational modification of protein domains, interactions with binding proteins, and the nature of the engaged and resulting features of nucleosomes in the proximity of target genes. In general, MTA1 and MTA2 are the most upregulated genes in human cancer and correlate well with aggressive phenotypes, therapeutic resistance, poor prognosis and ultimately, unfavorable survival of cancer patients. Here we will discuss the structure, expression and functions of the MTA family of genes in the context of cancer cells.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Chromatin remodeling; Coregulators; MTA1; MTA2; MTA3; Metastasis

Mesh:

Substances:

Year:  2016        PMID: 26869315      PMCID: PMC4785049          DOI: 10.1016/j.gene.2016.02.012

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  109 in total

1.  Deacetylation of p53 modulates its effect on cell growth and apoptosis.

Authors:  J Luo; F Su; D Chen; A Shiloh; W Gu
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

2.  MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation.

Authors:  Naoyuki Fujita; David L Jaye; Cissy Geigerman; Adil Akyildiz; Myesha R Mooney; Jeremy M Boss; Paul A Wade
Journal:  Cell       Date:  2004-10-01       Impact factor: 41.582

3.  Metastasis-associated protein 2 (MTA2) promotes the metastasis of non-small-cell lung cancer through the inhibition of the cell adhesion molecule Ep-CAM and E-cadherin.

Authors:  Bin Zhang; Hao Zhang; Gang Shen
Journal:  Jpn J Clin Oncol       Date:  2015-05-11       Impact factor: 3.019

Review 4.  Properties and clinical relevance of MTA1 protein in human cancer.

Authors:  Yasushi Toh; Garth L Nicolson
Journal:  Cancer Metastasis Rev       Date:  2014-12       Impact factor: 9.264

5.  MTA1, a transcriptional activator of breast cancer amplified sequence 3.

Authors:  Anupama E Gururaj; Rajesh R Singh; Suresh K Rayala; Caroline Holm; Petra den Hollander; Hao Zhang; Seetharaman Balasenthil; Amjad H Talukder; Goran Landberg; Rakesh Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-14       Impact factor: 11.205

6.  A core chromatin remodeling factor instructs global chromatin signaling through multivalent reading of nucleosome codes.

Authors:  Sujit S Nair; Da-Qiang Li; Rakesh Kumar
Journal:  Mol Cell       Date:  2013-01-24       Impact factor: 17.970

7.  Metastasis-associated protein 1 promotes tumor invasion by downregulation of E-cadherin.

Authors:  Wenhao Weng; Jiayi Yin; Yue Zhang; Jin Qiu; Xinghe Wang
Journal:  Int J Oncol       Date:  2014-01-10       Impact factor: 5.650

8.  The metastasis-associated genes MTA1 and MTA3 are abundantly expressed in human placenta and chorionic carcinoma cells.

Authors:  Ansgar Brüning; Josef Makovitzky; Andrea Gingelmaier; Klaus Friese; Ioannis Mylonas
Journal:  Histochem Cell Biol       Date:  2009-04-12       Impact factor: 4.304

Review 9.  Towards an understanding of the structure and function of MTA1.

Authors:  Christopher J Millard; Louise Fairall; John W R Schwabe
Journal:  Cancer Metastasis Rev       Date:  2014-12       Impact factor: 9.264

10.  Estrogen regulates the tumour suppressor MiRNA-30c and its target gene, MTA-1, in endometrial cancer.

Authors:  Xiangyi Kong; Xiaofeng Xu; Yuhua Yan; Feifei Guo; Jian Li; Yali Hu; Huaijun Zhou; Qingying Xun
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

View more
  29 in total

Review 1.  Signaling coupled epigenomic regulation of gene expression.

Authors:  R Kumar; S Deivendran; T R Santhoshkumar; M R Pillai
Journal:  Oncogene       Date:  2017-06-26       Impact factor: 9.867

2.  Effects of histone deacetylase inhibitory prodrugs on epigenetic changes and DNA damage response in tumor and heart of glioblastoma xenograft.

Authors:  Nataly Tarasenko; Abraham Nudelman; Gabriela Rozic; Suzanne M Cutts; Ada Rephaeli
Journal:  Invest New Drugs       Date:  2017-03-17       Impact factor: 3.850

3.  Cytoplasmic translocation of MTA1 coregulator promotes de-repression of SGK1 transcription in hypoxic cancer cells.

Authors:  H Marzook; S Deivendran; B George; G Reshmi; T R Santhoshkumar; R Kumar; M R Pillai
Journal:  Oncogene       Date:  2017-05-15       Impact factor: 9.867

4.  Interplay between 15-lipoxygenase-1 and metastasis-associated antigen 1 in the metastatic potential of colorectal cancer.

Authors:  S Tunçer; S Tunçay Çağatay; A G Keşküş; M Çolakoğlu; Ö Konu; S Banerjee
Journal:  Cell Prolif       Date:  2016-06-19       Impact factor: 6.831

5.  Epigenetic Regulation by Agonist-Specific Aryl Hydrocarbon Receptor Recruitment of Metastasis-Associated Protein 2 Selectively Induces Stanniocalcin 2 Expression.

Authors:  Aditya D Joshi; Ekram Hossain; Cornelis J Elferink
Journal:  Mol Pharmacol       Date:  2017-07-10       Impact factor: 4.436

Review 6.  Regulatory Mechanisms of the LuxS/AI-2 System and Bacterial Resistance.

Authors:  Yang Wang; Baobao Liu; Daniel Grenier; Li Yi
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

Review 7.  Long Non-coding RNAs With In Vitro and In Vivo Efficacy in Preclinical Models of Esophageal Squamous Cell Carcinoma Which Act by a Non-microRNA Sponging Mechanism.

Authors:  Ulrich H Weidle; Fabian Birzele
Journal:  Cancer Genomics Proteomics       Date:  2022 Jul-Aug       Impact factor: 3.395

8.  CUL4B Promotes Breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway.

Authors:  Wei Huang; Jingyao Zhang; Miaomiao Huo; Jie Gao; Tianshu Yang; Xin Yin; Pei Wang; Shuai Leng; Dandan Feng; Yang Chen; Yang Yang; Yan Wang
Journal:  Adv Sci (Weinh)       Date:  2021-03-16       Impact factor: 16.806

9.  Organic Zinc and Copper Supplementation-Associated Changes in Gene Expression and Protein Profiles in Buck Spermatozoa.

Authors:  Venkata Krishnaiah Mayasula; Arangasamy Arunachalam; Selvaraju Sellappan; Pushpa Rani Guvvala; Jyotirmoy Ghosh
Journal:  Biol Trace Elem Res       Date:  2021-07-08       Impact factor: 3.738

10.  FOXP3 Inhibits the Metastasis of Breast Cancer by Downregulating the Expression of MTA1.

Authors:  Chenlin Liu; Jun Han; Xiaoju Li; Tonglie Huang; Yuan Gao; Baolong Wang; Kuo Zhang; Shuning Wang; Wangqian Zhang; Weina Li; Qiang Hao; Meng Li; Yingqi Zhang; Cun Zhang
Journal:  Front Oncol       Date:  2021-07-07       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.